ACQUISITION OF ANTIVENOM SERUMS FOR PERSONNEL OF THE EL TAMBO MILITARY BASE FOR THE FIGHT AGAINST ILLEGAL MINING OF THE SIXTH JUNGLE BRIGADE AF-2025

This tender, issued by the Peruvian Army (EJERCITO PERUANO), concerns the acquisition of antivenom serums. These serums are intended for the personnel stationed at the El Tambo Military Base, a facility operated by the Sixth Jungle Brigade (SEXTA BRIGADA DE SELVA). The primary objective of this procurement is to support the ongoing efforts to combat illegal mining activities within the brigade's operational area. The tender is specifically designated for the fiscal year 2025 (AF-2025).

The contracting entity is the Peruvian Army, and the procurement process is being managed under the reference COMPRE-COMPRE-3-2025-EP/UO 0808-1. The location relevant to this acquisition is the department of Lima. The method of contracting chosen for this process is Price Comparison (Comparación de Precios), indicating a streamlined approach to selecting a supplier based on competitive pricing.

This acquisition is critical for ensuring the health and safety of military personnel who operate in regions where encounters with venomous snakes are a significant risk, particularly in the context of combating illegal mining. The availability of adequate antivenom is essential for immediate medical response in case of snakebites, thereby maintaining operational readiness and protecting the lives of soldiers engaged in challenging duties.

This is a supplies contract in the health and medical services, mining and extractives and general supplies sectors. Located in Peru, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of PEN 60,000.

Published through Peru SEACE, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.